Document de presse | 2015.06.24
Sequencing the genome of Ebola virus strains circulating in Guinea has allowed scientists at the Institut Pasteur in Dakar and in Paris, the CNRS and the University of Sydney to retrace the spread of the virus and monitor its evolution in the country where the outbreak started. This research reveals the co-circulation in Guinea, particularly in the urban regions of the capital and neighboring...
Document de presse | 2015.11.10
Scientists at the Institut Pasteur in Cambodia, the Institut Pasteur in Paris and the CNRS provided proof that people infected by dengue virus but showing no clinical symptoms can actually infect mosquitoes that bite them. It appears that these asymptomatic people – who, together with mildly symptomatic patients, represent three-quarters of all dengue infections – could be involved in...
Document de presse | 2014.06.11
Using the 2005-2006 chikungunya virus epidemic that occurred in the Indian Ocean islands as a study model, researchers at the Pasteur Institute have succeeded in developing an approach that can predict the virus mutations most likely to emerge in the short-term, with strong epidemic potential. This work has strong implications for improving surveillance of ongoing epidemics and the potential to...
Document de presse | 2012.01.22
Today, Monday January 23, 2012, in Vientiane the launch of the Institut Pasteur in Laos was officiated by the Lao Minister of Public Health, professor Som Ock Kingsadat and the President of the Institut Pasteur in Paris, professor Alice Dautry. This is the Institut Pasteur International Network’s 32nd institute. The new research center for infectious and parasitic diseases aims to reduce...
News | 2017.09.29
The African Academy of Sciences and the NEPAD Agency’s Alliance for Accelerating Excellence in Science in Africa (AESA) announced funding for eight African innovators to tackle maternal, neonatal and child health on the Continent. Among them 2 teams from the Institut Pasteur in Dakar and one from the Institut Pasteur in Madagascar were selected from among about 400 applicants from 20 African...
News | 2017.12.13
From December 14, 2017 to August 19, 2018, the Palais de la découverte in Paris is hosting an exhibition entitled "Pasteur, the experimenter" ("Pasteur, l'expérimentateur"). The exhibition, curated by Universcience in collaboration with the Institut Pasteur, looks at Louis Pasteur's career – his many and varied research fields, his talent as an experimenter and also his links with art, technology...
Document de presse | 2019.05.09
Nipah virus, a bat-borne paramyxovirus found throughout South and South East Asia, has been identified by WHO as an emerging infectious disease that may cause severe epidemics in the near future. Infections in humans result in severe respiratory and neurological disease with a high case fatality. With no available treatment or vaccine, the control of Nipah virus outbreaks must rely on a detailed...
News | 2020.02.06
Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa and affects especially underserved people. Yet, since the first vaccine developed by Louis Pasteur more than 130 years ago, prophylactic measures have significantly improved. They are now composed of the vaccine allied to purified human or equine rabies immunoglobulins. However, these...
News | 2020.12.02
Before the vaccine era, diphtheria was the most deadly respiratory infection in young children. There are still outbreaks of diphtheria in some world regions and cases can occur among unvaccinated individuals, with severe consequences. Antibiotics are vital in treating diphtheria, and the emergence of antibiotic resistance is a major public health concern. A team of Institut Pasteur scientists...
Document de presse | 2021.04.21
Drawing on epidemiological field studies and the FrenchCOVID hospital cohort coordinated by Inserm, teams from the Institut Pasteur, the CNRS and the Vaccine Research Institute (VRI, Inserm/University Paris-Est Créteil) studied the antibodies induced in individuals with asymptomatic or symptomatic SARS-CoV-2 infection. The scientists demonstrated that infection induces polyfunctional antibodies....